Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease
| Status: | Recruiting |
|---|---|
| Conditions: | Arthritis, Lung Cancer, Rheumatoid Arthritis, Pulmonary, Pulmonary |
| Therapuetic Areas: | Oncology, Pulmonary / Respiratory Diseases, Rheumatology |
| Healthy: | No |
| Age Range: | 18 - 90 |
| Updated: | 10/4/2018 |
| Start Date: | June 22, 2017 |
| End Date: | June 2027 |
| Contact: | Lina Stanchev, MS |
| Email: | LINA.STANCHEV@UCDENVER.EDU |
| Phone: | 303-724-9469 |
The overall goal of this study is to define the phenotype of Interstitial Lung Disease (ILD)
in patients with rheumatoid arthritis (RA). The investigators hypothesize that there are
common elements between other forms of ILD such as idiopathic pulmonary fibrosis (IPF) and
sub-clinical RA-ILD that places individuals at risk for the development of lung disease.
This is not a treatment study. It is a protocol designed to enroll individuals affected by RA
and explore associated lung disease so that the investigators can better understand the
clinical phenotype and genetic and molecular endotypes of this disease.
in patients with rheumatoid arthritis (RA). The investigators hypothesize that there are
common elements between other forms of ILD such as idiopathic pulmonary fibrosis (IPF) and
sub-clinical RA-ILD that places individuals at risk for the development of lung disease.
This is not a treatment study. It is a protocol designed to enroll individuals affected by RA
and explore associated lung disease so that the investigators can better understand the
clinical phenotype and genetic and molecular endotypes of this disease.
Inclusion Criteria:
- Diagnosis of RA using the 2010 American College of Rheumatology (ACR) criteria
Exclusion Criteria:
- Inability to give informed consent
- Pregnant women
- History of Interstitial Lung Disease
- Evidence of other cause of diffuse parenchymal lung disease such as infection, drug
toxicity, other autoimmune processes, etc.
We found this trial at
1
site
13001 E 17th Pl
Aurora, Colorado 80045
Aurora, Colorado 80045
(303) 724-5000
Principal Investigator: Joce Lee, MD
Phone: 303-724-9469
University of Colorado Anschutz Medical Campus Located in the Denver metro area near the Rocky...
Click here to add this to my saved trials
